Dogwood Therapeutics
$2.11
47
-$0.02-0.94% Thursday 20:00
Statistics
Day High
2.19
Day Low
2.06
52W High
9.5
52W Low
1.77
Volume
18,250
Avg. Volume
57,929
Mkt Cap
4.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.193333
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-25.73MNet Income
Analyst Ratings
$12.00Average Price Target
The highest estimate is 12.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DWTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Merck
MRK
Mkt Cap214.76B
GSK
GSK
Mkt Cap94.51B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novartis
NVS
Mkt Cap237.61B
About
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Show more...
CEO
Mr. Gregory Duncan
Employees
12
Country
US
ISIN
US92829J2033
Listings
0 Comments
Share your thoughts
FAQ
What is Dogwood Therapeutics stock price today?▼
The current price of DWTX is $2.11 USD — it has decreased by -0.94% in the past 24 hours. Watch Dogwood Therapeutics stock price performance more closely on the chart.
What is Dogwood Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Dogwood Therapeutics stocks are traded under the ticker DWTX.
Is Dogwood Therapeutics stock price growing?▼
DWTX stock has risen by +6.57% compared to the previous week, the month change is a -31.72% fall, over the last year Dogwood Therapeutics has showed a -50.35% decrease.
What is Dogwood Therapeutics market cap?▼
Today Dogwood Therapeutics has the market capitalization of 4.84M
When is the next Dogwood Therapeutics earnings date?▼
Dogwood Therapeutics is going to release the next earnings report on May 07, 2026.
What were Dogwood Therapeutics earnings last quarter?▼
DWTX earnings for the last quarter are -0.26 USD per share, whereas the estimation was -0.86 USD resulting in a +69.77% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dogwood Therapeutics revenue for the last year?▼
Dogwood Therapeutics revenue for the last year amounts to 0 USD.
What is Dogwood Therapeutics net income for the last year?▼
DWTX net income for the last year is -25.73M USD.
How many employees does Dogwood Therapeutics have?▼
As of April 04, 2026, the company has 12 employees.
In which sector is Dogwood Therapeutics located?▼
Dogwood Therapeutics operates in the Health Care sector.
When did Dogwood Therapeutics complete a stock split?▼
The last stock split for Dogwood Therapeutics was on October 09, 2024 with a ratio of 1:25.
Where is Dogwood Therapeutics headquartered?▼
Dogwood Therapeutics is headquartered in Alpharetta, US.